ArticleBMC anesthesiology2019

MiR-34a affects dexmedetomidine-inhibited chronic inflammatory visceral pain by targeting to HDAC2.

Meng Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.